Proteinuria is associated with quality of life and depression in adults with primary glomerulopathy and preserved renal function

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Libório, Alexandre Braga ^a,b   Santos, João Paulo Lima ^a   Minete, Natália Feitosa Arraes ^a   Diógenes, Cecília de Alencar ^a   Soares, Ariane Pontes ^a   Queiroz, Anaiara Lucena ^b   Barreto, Dulce Maria Silva ^b  

^a UNIVERSITY OF FORTALEZA   (Brazil)

^b HOSPITAL GERAL DE FORTALEZA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; PROTEIN; STEROID;

ADULT; AGE DISTRIBUTION; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HAMILTON SCALE; HEMODIALYSIS PATIENT; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; PREVALENCE; PRIMARY GLOMERULOPATHY; PROTEINURIA; QUALITY OF LIFE; RISK FACTOR; SEX DIFFERENCE; SHORT FORM 36; URINARY EXCRETION;

ADULT; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PREVALENCE; PROTEINURIA; QUALITY OF LIFE; RISK FACTORS;

EID: 84861477805     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037763     Document Type: Article

References (30)

1. Malafronte P, Mastroianni-Kirsztajn G, Betônico GN, Romão JE, Alves MA, et al. (2006) Paulista Registry of glomerulonephritis: 5-year data report. Nephrol Dial Transplant 21: 3098-3105.
2. Mazairac AH, de Wit GA, Penne LE, van der Weerd NC, Grooteman MP, et al. (2010) Protein-Energy Nutritional Status and Kidney Disease-specific Quality of Life in Hemodialysis Patients. J Ren Nutr.
3. Miettola J, Niskanen LK, Viinamäki H, Sintonen H, Kumpusalo E, (2008) Metabolic syndrome is associated with impaired health-related quality of life: Lapinlahti 2005 study. Qual Life Res 17: 1055-1062.
4. Perlman RL, Finkelstein FO, Liu L, Roys E, Kiser M, et al. (2005) Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis 45: 658-666.
5. Snow V, Lascher S, Mottur-Pilson C, (2000) Pharmacologic treatment of acute major depression and dysthymia. American College of Physicians-American Society of Internal Medicine. Ann Intern Med 132: 738-742.
6. Simon GE, (2001) Treating depression in patients with chronic disease: recognition and treatment are crucial; depression worsens the course of a chronic illness. West J Med 175: 292-293.
7. Omachi TA, Katz PP, Yelin EH, Gregorich SE, Iribarren C, et al. (2009) Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med 122: 778.e9-778.15.
8. Saveanu RV, Mayes T, (2011) Diagnosing depression in congestive heart failure. Heart Fail Clin 7: 75-79.
9. Cohen SD, Norris L, Acquaviva K, Peterson RA, Kimmel PL, (2007) Screening, diagnosis, and treatment of depression in patients with end-stage renal disease. Clin J Am Soc Nephrol 2: 1332-1342.
10. Kimmel PL, Peterson RA, (2006) Depression in patients with end-stage renal disease treated with dialysis: has the time to treat arrived? Clin J Am Soc Nephrol 1: 349-352.
11. Kennedy SH, Eisfeld BS, Cooke RG, (2001) Quality of life: an important dimension in assessing the treatment of depression? J Psychiatry Neurosci 26 (Suppl): S23-S28.
12. Gokal R, (1993) Quality of life in patients undergoing renal replacement therapy. Kidney Int Suppl 40: S23-S27.
13. Finkelstein FO, Wuerth D, Finkelstein SH, (2009) Health related quality of life and the CKD patient: challenges for the nephrology community. Kidney Int 76: 946-952.
14. Gipson DS, Trachtman H, Kaskel FJ, Radeva MK, Gassman J, et al. (2011) Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. Kidney Int 79: 678-685.
15. Aguiar CC, Vieira AP, Carvalho AF, Montenegro-Junior RM, (2008) [Assessment instruments for a Health-Related Quality of Life in diabetes mellitus]. Arq Bras Endocrinol Metabol 52: 931-939.
16. Fleck MP, Chaves ML, Poirier-Littré MF, Bourdel MC, Loo H, et al. (2004) Depression in France and Brazil: factorial structure of the 17-item Hamilton Depression Scale in inpatients. J Nerv Ment Dis 192: 103-110.
17. Valderrábano F, Jofre R, López-Gómez JM, (2001) Quality of life in end-stage renal disease patients. Am J Kidney Dis 38: 443-464.
18. Cameron JI, Whiteside C, Katz J, Devins GM, (2000) Differences in quality of life across renal replacement therapies: a meta-analytic comparison. Am J Kidney Dis 35: 629-637.
19. Abdel-Kader K, Unruh ML, Weisbord SD, (2009) Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clin J Am Soc Nephrol 4: 1057-1064.
20. Rüth EM, Landolt MA, Neuhaus TJ, Kemper MJ, (2004) Health-related quality of life and psychosocial adjustment in steroid-sensitive nephrotic syndrome. J Pediatr 145: 778-783.
21. (1994) American Psychiatric Association: Diagnosis and Statistical of Mental Disorders, 4th Ed Washington, D.C. American Psychiatric Association.
22. Dogra GK, Herrmann S, Irish AB, Thomas MA, Watts GF, (2002) Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome. Nephrol Dial Transplant 17: 2220-2225.
23. Farag YM, Keithi-Reddy SR, Mittal BV, Surana SP, Addabbo F, et al. (2011) Anemia, inflammation and health-related quality of life in chronic kidney disease patients. Clin Nephrol 75: 524-533.
24. Kalender B, Ozdemir AC, Koroglu G, (2006) Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease. Nephron Clin Pract 102: c115-c121.
25. Painter PL, Topp KS, Krasnoff JB, Adey D, Strasner A, et al. (2003) Health-related fitness and quality of life following steroid withdrawal in renal transplant recipients. Kidney Int 63: 2309-2316.
26. Zhu WL, Shi HS, Wang SJ, Wu P, Ding ZB, Lu L, (2011) Hippocampal CA3 calcineurin activity participates in depressive-like behavior in rats. J Neurochem 117: 1075-1086.
27. Faller H, Störk S, Schuler M, Schowalter M, Steinbüchel T, et al. (2009) Depression and disease severity as predictors of health-related quality of life in patients with chronic heart failure-a structural equation modeling approach. J Card Fail 15: 286-292.e2.
28. Unützer J, (2007) Clinical practice. Late-life depression. N Engl J Med 357: 2269-2276.
29. Taner E, Coşar B, Burhanoǧlu S, Calikoǧlu E, Onder M, Arikan Z, (2007) Depression and anxiety in patients with Behçet's disease compared with that in patients with psoriasis. Int J Dermatol 46: 1118-1124.
30. Almawi W, Tamim H, Al-Sayed N, Arekat MR, Al-Khateeb GM, et al. (2008) Association of comorbid depression, anxiety, and stress disorders with Type 2 diabetes in Bahrain, a country with a very high prevalence of Type 2 diabetes. J Endocrinol Invest 31: 1020-1024.